Skip to content KD Chem Pharma Manufacturer of Pharmaceutical and Nutraceutical Products KD Chem Pharma Manufacturer of Pharmaceutical and Nutraceutical Products Your Brand, Your Label Description Reviews (0) Benefits Ubiquinol (CoQ10), L-carnitine L-tartrate, astaxanthin, zinc, lycopene, and sodium selenate tablets offer benefits such as supporting heart health, promoting energy production, providing antioxidant defense, and supporting overall well-being
Vihar - Lifestyle as Medicine Vihar focuses on the habits, routines, and environment that shape overall health
Natural Medicines Comprehensive Database
But now that Novo and Lilly have caught up with demand, the FDA said that large-scale compounding must stop
Treat your research supplies with the same respect you'd treat surgical instruments

FDA's 2026 GLP-1 Warnings: 990 Reports and What They Mean for JoinSkinny Patients FDA has published ongoing warnings about compounded GLP-1 products generally: Dosing errors from measuring doses out of multi-dose vials Use of salt forms (like semaglutide sodium) that haven't been proven safe or effective Adverse events, including hospitalization in some cases As of May 31, 2026: 990 adverse-event reports tied to compounded semaglutide, and more than 730 tied to compounded tirzepatide - FDA notes these reports may be incomplete and don't, by themselves, establish that a compounded drug caused the reported event On April 30, 2026: FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list - a move that would close the main legal pathway for large-scale outsourcing-facility compounding of these drugs absent a shortage, with a public comment period that ran through June 29, 2026 These are industry-wide regulatory developments, not findings against JoinSkinny or any specific pharmacy named in this article
